At NSN Unlimited, we maintain a large database of parts NDC51672-4042-02, NDC00591-0363-05, NDC00536-4940-05, NDC00378-0030-05, NDC00364-2201-05 with NSN 6505-01-252-0802 used in civil and defense applications for the aerospace, marine, and commercial manufactured by Taro Pharmaceuticals Usa Inc, Danbury Pharmacal Inc, Rugby Group Inc, Mylan Pharmaceuticals Inc, Schein Henry Inc. Utilize our interface to browse items by part number, part type, manufacturer, and more. Obtain insights on top MRO and FBO services, Manufacturer profiles, and part catalogs.
With an unmatched supply-chain network, we are able to provide expedited shipping and same-day or next-day delivery on qualifying parts.
Ready for a quote? Submit an Instant RFQ today for NSN 6505-01-252-0802.
| Alternative NSN: 6505-01-252-0802 |
| Item Name: Clorazepate Dipotassium Tablets Usp |
| NIIN: 012520802 |
| NCB Code: USA (01) |
| Manufacturers: Taro Pharmaceuticals Usa Inc , Danbury Pharmacal Inc , Rugby Group Inc , Mylan Pharmaceuticals Inc , Schein Henry Inc , Actavis Inc , Abbott Laboratories Inc , Warner Lambert Ltd |
| Part No | NSN | Item Name | Manufacturer | QTY | RFQ |
|---|---|---|---|---|---|
| NDC51672-4042-02 | 6505-01-252-0802 | clorazepate dipotassium tablets usp | taro pharmaceuticals usa inc | Avl | RFQ |
| NDC00591-0363-05 | 6505-01-252-0802 | clorazepate dipotassium tablets usp | danbury pharmacal inc | Avl | RFQ |
| NDC00536-4940-05 | 6505-01-252-0802 | clorazepate dipotassium tablets usp | rugby group inc | Avl | RFQ |
| NDC00378-0030-05 | 6505-01-252-0802 | clorazepate dipotassium tablets usp | mylan pharmaceuticals inc | Avl | RFQ |
| NDC00364-2201-05 | 6505-01-252-0802 | clorazepate dipotassium tablets usp | schein henry inc | Avl | RFQ |
| NDC00228-3067-50 | 6505-01-252-0802 | clorazepate dipotassium tablets usp | actavis inc | Avl | RFQ |
| NDC00074-4389-53 | 6505-01-252-0802 | clorazepate dipotassium tablets usp | abbott laboratories inc | Avl | RFQ |
| NDC00047-0451-30 | 6505-01-252-0802 | clorazepate dipotassium tablets usp | warner lambert ltd | Avl | RFQ |
| 4389-53 | 6505-01-252-0802 | clorazepate dipotassium tablets usp | abbott laboratories inc | Avl | RFQ |
| MRC | Criteria | Characteristic |
|---|---|---|
| AJCN | PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
| FEAT | SPECIAL FEATURES | SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 500S BT |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
All Orders are Fulfilled in the U.S.A.
All shipments must comply with U.S.A export laws.
No exceptions.
The only independent distributor
with a NO CHINA SOURCING Pledge
“We Proudly Support Intrepid Fallen Heroes Fund that serves United States Military Personal experiencing the Invisible Wounds of War : Traumatic Brain Injury (TBI) and Post Traumatic Stress (PTS). Please visit website (www.fallenheroesfund.org) and help in their valiant effort”.
If You’d Like to Stay Up to Date On Our Latest, Up-To-Date NSN Parts; Kindly Explore Our Catalog and Get Quote for Your Required Part Number.
Request for Quote
